DEXMEDETOMIDINE MYLAN, DEXMEDETOMIDINE ALPHAPHARM (Alphapharm Pty Ltd)
Product name
DEXMEDETOMIDINE MYLAN, DEXMEDETOMIDINE ALPHAPHARM
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
152 working days (255)
Active ingredients
dexmedetomidine hydrochloride
Registration type
New generic medicine
Indication
DEXMEDETOMIDINE MYLAN, DEXMEDETOMIDINE ALPHAPHARM (injection) is indicated for:
ICU Sedation
For sedation of initially intubated patients during treatment in an intensive care setting
- Procedural Sedation
For sedation of non-intubated patients prior to and/or during surgical and other procedures.